SEARCH

SEARCH BY CITATION

References

  • Allen J. W., Eldadah B. A. and Faden A. I. (1999) Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: exacerbation by selective inhibition of group I metabotropic glutamate receptors. Neuropharmacology 38, 12431252.
  • Bao W. L., Williams A. J., Faden A. I. and Tortella F. C. (2001) Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res. 922, 173179.
  • Beals C. R., Sheridan C. M., Turck C. W., Gardner P. and Crabtree G. R. (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 19301934.
  • Bhat R. V., Budd Haeberlein S. L. and Avila J. (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89, 13131317.
  • Brewer G. J. and Price P. J. (1996) Viable cultured neurons in ambient carbon dioxide and hibernation storage for a month. Neuroreport 7, 15091512.
  • Brewer G. J., Torricelli J. R., Evege E. K. and Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567576.
  • Brunet A., Datta S. R. and Greenberg M. E. (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297305.
  • Bruno V., Ksiazek I., Battaglia G., Lukic S., Leonhardt T., Sauer D., Gasparini F., Kuhn R., Nicoletti F. and Flor P. J. (2000) Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology 39, 22232230.
  • Copani A., Bruno V. M., Barresi V., Battaglia G., Condorelli D. F. and Nicoletti F. (1995) Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. J. Neurochem. 64, 101108.
  • Dajani R., Fraser E., Roe S. M., Young N., Good V., Dale T. C. and Pearl L. H. (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721732.
  • Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R. and Greenberg M. E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661665.
  • Frame S., Cohen P. and Biondi R. M. (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7, 13211327.
  • Grimes C. A. and Jope R. S. (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391426.
  • Hetman M., Cavanaugh J. E., Kimelman D. and Xia Z. (2000) Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20, 25672574.
  • Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N. and Sato K. (2003) Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc. Natl Acad. Sci. USA 100, 63706375.
  • Hou L. and Klann E. (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24, 63526361.
  • Imahori K. and Uchida T. (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. (Tokyo) 121, 179188.
  • Jope R. S. and Johnson G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95102.
  • Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T. and Akaike A. (2001) alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J. Biol. Chem. 276, 13 54113 546.
  • Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R. and Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 2739.
  • Maiese K. and Vincent A. M. (1999) Group I metabotropic receptors down-regulate nitric oxide induced caspase-3 activity in rat hippocampal neurons. Neurosci. Lett. 264, 1720.
  • Martin D., Salinas M., Lopez-Valdaliso R., Serrano E., Recuero M. and Cuadrado A. (2001) Effect of the Alzheimer amyloid fragment Abeta (25–35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 78, 10001008.
  • Movsesyan V. A., Stoica B. A. and Faden A. I. (2004) MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J. Neurochem. 89, 15281536.
  • Nicoletti F., Bruno V., Catania M. V., Battaglia G., Copani A., Barbagallo G., Cena V., Sanchez-Prieto J., Spano P. F. and Pizzi M. (1999) Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology 38, 14771484.
  • Nishi A., Liu F., Matsuyama S., Hamada M., Higashi H., Nairn A. C. and Greengard P. (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc. Natl Acad. Sci. USA 100, 13221327.
  • Pei J. J., Tanaka T., Tung Y. C., Braak E., Iqbal K. and Grundke-Iqbal I. (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J. Neuropathol Exp. Neurol. 56, 7078.
  • Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B. and Cowburn R. F. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol Exp. Neurol. 58, 10101019.
  • Rong R., Ahn J. Y., Huang H., Nagata E., Kalman D., Kapp J. A., Tu J., Worley P. F., Snyder S. H. and YeK. (2003) PI3 kinase enhancer–Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci. 6, 11531161.
  • Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K. and Imahori K. (1996) Exposure of rat hippocampal neurons to amyloid beta peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci. Lett. 203, 3336.
  • Xavier I. J., Mercier P. A., McLoughlin C. M., Ali A., Woodgett J. R. and Ovsenek N. (2000) Glycogen synthase kinase 3beta negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1. J. Biol. Chem. 275, 29 14729 152.
  • Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A. and Imahori K. (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. (Berl.) 92, 232241.
  • Zhang L., Rubinow D. R., Xaing G., Li B. S., Chang Y. H., Maric D., Barker J. L. and Ma W. (2001) Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12, 19191923.